{"status":"OK","data":{"advertisement":{"id":218108,"title":"Zapytanie ofertowe 10 07 2023 A","partial_offer_allowed":false,"publication_date":"2023-07-12","submission_deadline":"2023-07-17 23:59:59","planned_sign_date":"2023-07-01","supplementary_orders":"The Ordering Party reserves the right to amend the provisions of the Agreement in relation to the content of the final tender, on the basis of which the Bidder has been selected in terms of the order size when the changes concern the provision of additional services not covered by the basic order (supplementary orders), the value of each subsequent change will not exceed 50% of the value of the order originally specified in the contract. The maximum number of samples to test/number of experiments to perform including supplementary orders will not exceed 30.","terms_of_contract_change":"The Ordering Party reserves the right to amend the provisions of the Agreement in relation to the content of the final tender, on the basis of which the Bidder has been selected:\na) term of the contract \u2013 the Ordering Party reserves the right to change the expected date of completion of the contract following changes in the scope of the signed contract for co-financing Project (extension of the duration of the Project, extension of appropriate stages of the Project, change of research plans);\nb) when the changes concern the provision of additional services not covered by the basic order (supplementary orders), the value of each subsequent change will not exceed 50% of the value of the order originally specified in the contract. The maximum number of samples to test/number of experiments to perform including supplementary orders will not exceed 30.\nc) order size - The Ordering Party reserves the right not to complete the subject of the order in the full, estimated quantity to be ordered (Table above \u2013 column \"Number of samples to test/number of experiments\"). The minimum Number of samples to test/number of experiments is 1. The Supplier shall not be entitled to a claim in this respect.\nd) unit prices of the subject of the contract - the Ordering Party allows a change in the amount of remuneration (price indexation). For this purpose, the Supplier shall provide the Ordering Party with reasonable reasons why it is not possible to maintain the price specified in the offer. Such causes may be, in particular, but without limitation, force majeure, unexpected or unforeseen or unavoidable market failures resulting in unavailability or difficulties in obtaining raw materials on the market, general changes in prices on the market, changes resulting in restrictions imposed by the States Parties to the Agreement or the European Union, etc. The price increase determined in this way must be documented by the Contractor. The contractor may request the possibility of obtaining prices due to circumstances beyond his reasonable control, provided that the impact is higher than 10 %.\ne) in the event of force majeure, understood as an event which substantially impedes the performance of obligations under the grant agreement which the parties could not have foreseen and could not have prevented, and which they could not have overcome by acting with due diligence.","created_at":"2023-07-12 13:29:24","modified_at":"2023-07-18 00:00:03","contact_persons":[{"id":156,"forename":"Agnieszka","surname":"Gacek","phone_number":"12 314 03 06","email":"tenders@ryvu.com","created_by":null,"created_at":"2024-07-09 11:21:24","modified_at":"2024-07-09 11:21:24","modified_by":null}],"orders":[{"id":358108,"estimated_value":null,"order_items":[{"id":404980,"description":"hERG automated patch clamp\nIC50 assessment, at least 5 concentrations, in duplicate (N=2).\n\nMinimum number of samples to test/number of experiments to perform during the term of the contract is 1.\nEstimated number of samples to test/number of experiments to perform during the term of the contract is 20.\nIf it is necessary to order a test on a larger quantity, the Ordering Party reserves the right to award supplementary orders during the contract period. The maximum number of samples to test/number of experiments to perform including supplementary orders will not exceed 30.","warranty_period":null,"cpv_items":[{"id":8514,"code":"73110000-6","name":"Us\u0142ugi badawcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null,"id":455435,"type":{"id":1,"name":"adres"},"group_uuid":"bf65569d-5d3e-4790-93c5-9a449b488cfd"}],"participation_conditions":[{"id":1107377,"description":"NO PERSONAL AND CAPITAL TIES\nTenderers, who are related by capital or personally to the Ordering Party (mutual relations between the Ordering Party or persons authorised to incur liabilities on behalf of the Ordering Party or persons performing activities related to the execution of the selection procedure on behalf of the Ordering Party and the Tenderer), shall be excluded from competing for the contract \u2013 the condition to be confirmed by a statement.\nCapital or personal links shall mean mutual links between the Ordering Party or persons authorised to incur liabilities on behalf of the Ordering Party or persons carrying out activities connected with the preparation and execution of the selection procedure on behalf of the Ordering Party and the Economic Operator, consisting in particular in:\n\u2212 participation in the company as a partner in a civil or other personal partnership;\n\u2212 holding at least 10% of shares or stocks;\n\u2212 acting as a member of a supervisory or managerial body, proxy, attorney;\n\u2212 being married, in a relationship of kinship or affinity in a straight line, kinship of the second degree or affinity of the second degree in a collateral line, or in a relationship of adoption, custody or guardianship.\nAssessment of the fulfillment of the above-mentioned condition will be made on the basis of a declaration signed by the Ordering Party.","type":{"id":7,"name":"Dodatkowe warunki udzia\u0142u"},"created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null,"group_uuid":"9c5246c3-73aa-4477-9660-f9756a6ddcfd"},{"id":1107378,"description":"Uzupe\u0142niony Appendix 1 (Za\u0142\u0105cznik 1)","type":{"id":6,"name":"Lista wymaganych dokument\u00f3w/o\u015bwiadcze\u0144"},"created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null,"group_uuid":"8124e518-ccf2-4fa0-9d08-a44b6b96faef"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null,"group_uuid":"dafacc58-7b59-4ab0-b26a-a9983283ae65"}],"evaluation_criteria":[{"id":618333,"price_criterion":true,"description":"Net price (\"C\") \u2013 weight: 100% (10 points).\nNet price (\"C\") should cover the performing of one test (which is the minimum number of tests to be performed under the contract).","created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null,"group_uuid":"94191533-c200-4492-be37-bf7b128628d2"}],"is_variant":false,"title":"hERG automated patch clamp","order_node":{"id":271868},"created_by":null,"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":null}],"created_by":{"id":112,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"RYVU THERAPEUTICS S.A.","identification_number_type":"nip","identification_number":"6792942955","address":{"country":"Polska","voivodeship":"ma\u0142opolskie","poviat":"Krak\u00f3w","commune":"Krak\u00f3w-Podg\u00f3rze","locality":"Krak\u00f3w","created_by":{"id":112,"contact_persons":[]},"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":{"id":112,"contact_persons":[]},"id":570466,"street":"Leona Sternbacha","number_description":"2","postcode":"30-394"},"created_by":{"id":112,"contact_persons":[]},"created_at":"2023-07-12 13:29:24","modified_at":"2023-07-12 13:29:24","modified_by":{"id":112,"contact_persons":[]},"id":218616},"advertisement":{"id":166007,"number":"2023-112-166007","publication_date":"2023-07-10","created_by":{"id":112,"contact_persons":[]},"created_at":"2023-07-10 13:30:48","modified_at":"2023-07-18 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[217713,218108],"enrollment":null,"projects":[{"id":104,"name":"Nowa terapia celowana nowotwor\u00f3w z delecj\u0105 genu MTAP","number":"0638/18","activity":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"region":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2022-02-10 21:45:42","modified_at":"2022-02-10 21:45:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"institution":null,"full_number":"POIR.01.01.01-00-0638/18","perspective":{},"programme":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"type":"project","created_by":{"id":112,"contact_persons":[]},"created_at":"2020-08-18 09:00:38","modified_at":"2020-08-18 09:00:38","modified_by":{"id":112,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":217713,"publication_date":"2023-07-10"},"id":1066325,"name":"Zapytanie ofertowe 10 07 2023 A","file":{"id":1188323,"name":"RFQ 10 07 2023 A.pdf","created_at":"2023-07-12 13:29:24","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1188323"},"group_uuid":"06f64c95-d12a-431a-bcde-9729840c2540"},{"origin":{"id":217713,"publication_date":"2023-07-10"},"id":1066326,"name":"Appendix 1 to RFQ 10 07 2023 A","file":{"id":1188324,"name":"Appendix to RFQ 10 07 2023 A.docx","created_at":"2023-07-12 13:29:24","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1188324"},"group_uuid":"b90d6ff5-c525-482e-8146-708d62ee16ef"},{"origin":{"id":218108,"publication_date":"2023-07-12"},"id":1069221,"name":"Questions and answers 10 07 2023 A","file":{"id":1191604,"name":"Questions and answers 10 07 2023 A.pdf","created_at":"2023-07-12 13:29:19","created_by":{"forename":"Aleksandra","surname":"Mazga\u0142a"},"uri":"/api/files/1191604"},"group_uuid":"aef9826a-25e5-47e3-a2a5-d547f1a92305"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}